[1]
„An Open Label Clinical Study Evaluating the Effectiveness of a Cryptolepis sanguinolenta based Herbal Antimalarial Agent“, AJBR, Bd. 22, Nr. 3, S. 257–262, Dez. 2019, Zugegriffen: 10. April 2026. [Online]. Verfügbar unter: https://ojshostng.com/index.php/ajbr/article/view/1321